Banner
Uk.ResellerClub Launches New Promotion Offering Free .CO.UK Domains With Hosting Packages

LONDON, May 10, 2013 /PRNewswire/ --  Web Presence products provider Uk.ResellerClub have...

Wirecard Gains SriLankan Airlines As A New Customer In Asia

MUNICH, Germany, April 30, 2013 /PRNewswire/ -- Wirecard AG, provider of a globally accepted payment...

Global Payments Continues Focus On Mobile Payments In The UK

LONDON, March 28, 2013 /PRNewswire/ -- Global Payments is further strengthening its mobile payment...

Induced Pluripotent Stem Cell Industry Report

Stem cell research and experimentation has been in process for well over five decades and they...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll



ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced final results from a randomized, placebo-controlled, double-blind, phase 2 clinical trial with the selective MET inhibitor tivantinib as a single-agent, investigational, second-line treatment in hepatocellular carcinoma (HCC). The data are to be presented today at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) (abstract number 4006). 


Kids have to go to school when they are young. As a result, many of them take it for granted.  Once college education became a 'right' and the public relations campaign made it seem like college was the only route to success, the sense of entitlement kicked in there as well.  Today, more than a quarter (28%) of children expect their parents to pay at least half of their university fees and less than one in ten (8%) plan to even take a job to help fund college themselves. 

Research from Legal&General Investments found that more than a quarter of children expect their parents to foot at least half the bill for university. The survey of 1,000 children, aged between 6 and 15, offers an insight into the financial expectations of children from across the UK. 





The Reaxys(R) PhD Prize rewards original and innovative research in organic, organometallic and inorganic chemistry. Today, Reaxys announced the 45 finalists for the 2012 Reaxys PhD Prize. This international prize is open to all students studying for (or having completed in the last 12 months) a PhD in chemistry. All entries were reviewed by a board of more than 80 leading international chemists and judged for originality, innovation, importance to the field, applicability, rigor of approach and publication quality. 


Eisai announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Fycompa(R) (perampanel) as an adjunctive treatment of focal seizures, with or without secondarily generalized seizures, in patients with epilepsy aged 12 years and older.